British Empire Sec & Gen Tst PLC
23 August 2006
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS
To make a RIS notification as required by DR 3.1.4R(1) or DR 3.1.4l(1)(b)
1. Name of the issuer
British Empire Securities and General Trust plc
2. State whether notification is under DR 3.1.4R(1)(a) or DR 3.1.4l(1)(b) (s324/
328 CA1985) or both
DR3.1.4R
3. Name of the person discharging managerial responsibilities ('PDMR') /
director
Rosamund Blomfield-Smith
4. State whether the notification relates to a person connected with the PDMR /
Director and identify the connected person
No
5. Indicate whether the notification is in respect of a holding by the person(s)
referred to in 3 or 4 above or in respect of a non-beneficial interest
Person named in 3 above
6. Description of shares (including class), debentures, derivatives or financial
instruments relating to shares
Ordinary shares of 10p each
7. Name of registered shareholder(s) and, if more than one, number of shares
held by each of them
Mrs Rosamund Evelyn Vaughan
8. State the nature of the transaction
Market purchase
9. Number of shares, debentures or financial instruments relating to shares
acquired
1,554
10. Percentage of issued class acquired (treasury shares of that class being
disregarded)
0.0009%
11. Number of shares, debentures or financial instruments relating to shares
disposed
n/a
12. Percentage of issued class disposed (treasury shares of that class being
disregarded)
n/a
13. Price per share or value of the transaction
£4.409
14. Date and place of the transaction
27 July 2006 London
15. Total holding following this notification and percentage (treasury shares
being disregarded)
1,554 (0.0009%)
16. Date issuer informed of the transaction
23 August 2006
If a PDMR / Director has been granted option(s) by the issuer complete the
following boxes
17. Date of grant
n/a
18. Period during which or date on which it can be exercised
n/a
19. Total amount paid (if any) for grant of the option
n/a
20. Description of shares or debentures involved (class and number)
n/a
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at time of exercise
n/a
22. Total number of shares or debentures over which options held following this
notification
n/a
23. Any additional information
24. Name of contact and telephone number for queries
D Hayes, Phoenix Administration Services Limited - Secretary
Date of Notification
23 August 2006
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.